The Cost–Effectiveness Of Rivaroxaban For The Prevention Of Cardiovascular (Cv) Events In Patients With Acute Coronary Syndrome (Acs) In Turkey
Abstract
Authors
E Parali C. Deger O. Ozdemir N. Afsar S. Aykut Aka M. Degertekin O. Ergene Z. Ongen M. Ozdemir F. Sumer Z.S. Yilmaz M.O. Ozel